George R Washko: Influence Statistics

George R Washko

George R Washko

Pulmonary and Critical Care Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. | Division of Pulmonary and Critical Care Medicine Brigham and ...

George R Washko: Expert Impact

Concepts for which George R Washko has direct influence: Lung function , Interstitial lung abnormalities , Pulmonary disease , Chronic obstructive , Computed tomography , Obstructive pulmonary , Paraseptal emphysema .

George R Washko: KOL impact

Concepts related to the work of other authors for which for which George R Washko has influence: Chronic obstructive , Pulmonary disease , Lung function , Copd patients , Computed tomography , Cigarette smoke , Deep learning .

KOL Resume for George R Washko

Year
2022

Pulmonary and Critical Care Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Applied Chest Imaging Laboratory, Brigham and Women’s Hospital, Boston, MA

2021

Brigham and Women's Hospital and Harvard Medical School Boston, Massachusetts.

Harvard Medical School, Boston, Massachusetts, USA

The NHLBI Framingham Heart Study Framingham, Massachusetts and.

2020

Pulmonary and Critical Care Division, Brigham and Women's Hospital and Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA.

Department of Pulmonology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA

Brigham and Womens Hospital, Boston, MA, United States

2019

Equal contributors on this article

Division of Pulmonary and Critical Care Medicine, Boston, Mass; Applied Chest Imaging Laboratory, Brigham and Women's Hospital, Boston, Mass. Electronic address:

U.S. National Heart, Lung, and Blood Institute’s Framingham Heart Study, Framingham, Massachusetts

Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, MA, United States

Applied Chest Imaging Laboratory, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA

2018

Division of Pulmonary and Critical Care Medicine, Dept of Medicine, Brigham and Women's Hospital, Boston, MA, USA

29 Brigham and Women's Hospital Boston, Massachusetts; and.

Brigham and Women's Hospital, Pulmonary and Critical Care Medicine. 75 Francis St. Boston. Massachusetts. United States.

Prominent publications by George R Washko

KOL-Index: 15588 . RATIONALE: Acute exacerbations of chronic obstructive pulmonary disease (COPD) increase the risk of death and drive healthcare costs, but whether they accelerate loss of lung function remains controversial. Whether exacerbations in subjects with mild COPD or similar acute respiratory events in smokers without airflow obstruction affect lung function decline is unknown. OBJECTIVES: To ...
Known for Acute Exacerbations | Lung Function | Pulmonary Disease | Subjects Copd
KOL-Index: 15578 . RATIONALE: Muscle wasting in chronic obstructive pulmonary disease (COPD) is associated with a poor prognosis and is not readily assessed by measures of body mass index (BMI). BMI does not discriminate between relative proportions of adipose tissue and lean muscle and may be insensitive to early pathologic changes in body composition. Computed tomography (CT)-based assessments of the ...
Known for Pectoralis Muscle Area | Computed Tomography | Pulmonary Disease | Chronic Obstructive
KOL-Index: 15273 . BACKGROUND: Cigarette smoking is associated with emphysema and radiographic interstitial lung abnormalities. The degree to which interstitial lung abnormalities are associated with reduced total lung capacity and the extent of emphysema is not known. METHODS: We looked for interstitial lung abnormalities in 2416 (96%) of 2508 high-resolution computed tomographic (HRCT) scans of the lung ...
Known for Interstitial Lung Abnormalities | Lung Volumes | 95 P0001 | Emphysema Smokers
KOL-Index: 14673 . BACKGROUND: Acute exacerbations adversely affect patients with chronic obstructive pulmonary disease (COPD). Macrolide antibiotics benefit patients with a variety of inflammatory airway diseases. METHODS: We performed a randomized trial to determine whether azithromycin decreased the frequency of exacerbations in participants with COPD who had an increased risk of exacerbations but no ...
Known for Azithromycin Placebo | Exacerbations Copd | 1 Year | Pulmonary Disease
KOL-Index: 14382 . RATIONALE: Former smoking history and chronic obstructive pulmonary disease (COPD) are potential risk factors for osteoporosis and fractures. Under existing guidelines for osteoporosis screening, women are included but men are not, and only current smoking is considered. OBJECTIVES: To demonstrate the impact of COPD and smoking history on the risk of osteoporosis and vertebral fracture in ...
Known for Vertebral Fractures | Bone Density | Copd Patients | Osteoporosis Risk
KOL-Index: 14176 . RATIONALE AND OBJECTIVES: To evaluate the relationship between measurements of lung volume (LV) on inspiratory/expiratory computed tomography (CT) scans, pulmonary function tests (PFT), and CT measurements of emphysema in individuals with chronic obstructive pulmonary disease. MATERIALS AND METHODS: Forty-six smokers (20 females and 26 males; age range 46-81 years), enrolled in the Lung ...
Known for Lung Function | Ratio Lv | Expiratory Volume | Aged Pulmonary
KOL-Index: 13751 . BACKGROUND: Retrospective studies have shown that statins decrease the rate and severity of exacerbations, the rate of hospitalization, and mortality in chronic obstructive pulmonary disease (COPD). We prospectively studied the efficacy of simvastatin in preventing exacerbations in a large, multicenter, randomized trial. METHODS: We designed the Prospective Randomized Placebo-Controlled ...
Known for Patients Copd | Placebo Simvastatin | Prevention Exacerbations | Time Exacerbation
KOL-Index: 12996 . RATIONALE AND OBJECTIVES: Pulmonary vascular alteration is one of the characteristic features of chronic obstructive pulmonary disease (COPD). Recent studies suggest that vascular alteration is closely related to endothelial dysfunction and may be further influenced by emphysema. However, the relationship between morphological alteration of small pulmonary vessels and the extent of ...
Known for Small Pulmonary | Copd Correlations | Emphysema Laa950 | Airflow Limitation
KOL-Index: 12933 . RATIONALE: The small conducting airways are the major site of airflow obstruction in chronic obstructive pulmonary disease and may precede emphysema development. OBJECTIVES: We hypothesized a novel computed tomography (CT) biomarker of small airway disease predicts FEV1 decline. METHODS: We analyzed 1,508 current and former smokers from COPDGene with linear regression to assess predictors ...
Known for Fev1 Decline | Small Airway | Chronic Obstructive | Airflow Obstruction
KOL-Index: 12907 . BACKGROUND: Exacerbations of chronic obstructive pulmonary disease (COPD) are associated with accelerated loss of lung function and death. Identification of patients at risk for these events, particularly those requiring hospitalization, is of major importance. Severe pulmonary hypertension is an important complication of advanced COPD and predicts acute exacerbations, though pulmonary ...
Known for Acute Exacerbations | Pa Ratio | Pulmonary Arterial Enlargement | Disease Copd
KOL-Index: 12549 . RATIONALE: Few studies have examined associations between long-term exposure to fine particulate matter (PM2.5) and lung function decline in adults. OBJECTIVES: To determine if exposure to traffic and PM2.5 is associated with longitudinal changes in lung function in a population-based cohort in the Northeastern United States, where pollution levels are relatively low. METHODS: FEV1 and FVC ...
Known for Fine Particulate Matter | Function Decline | Traffic Emissions | Fev1 Fvc
KOL-Index: 12305 . IMPORTANCE: Airflow obstruction on spirometry is universally used to define chronic obstructive pulmonary disease (COPD), and current or former smokers without airflow obstruction may assume that they are disease free. OBJECTIVE: To identify clinical and radiologic evidence of smoking-related disease in a cohort of current and former smokers who did not meet spirometric criteria for COPD, ...
Known for Normal Spirometry | Gold 0 | United States | Life Smokers
KOL-Index: 12087 . RATIONALE: Pulmonary emphysema overlaps partially with spirometrically defined chronic obstructive pulmonary disease and is heritable, with moderately high familial clustering. OBJECTIVES: To complete a genome-wide association study (GWAS) for the percentage of emphysema-like lung on computed tomography in the Multi-Ethnic Study of Atherosclerosis (MESA) Lung/SNP Health Association ...
Known for Percent Emphysema | Computed Tomography | Lung Function | United States
KOL-Index: 11962 . RATIONALE: Vascular alteration of small pulmonary vessels is one of the characteristic features of pulmonary hypertension in chronic obstructive pulmonary disease. The in vivo relationship between pulmonary hypertension and morphological alteration of the small pulmonary vessels has not been assessed in patients with severe emphysema. OBJECTIVES: We evaluated the correlation of total ...
Known for Pulmonary Hypertension | Severe Emphysema | Computed Tomography | Correlation Csa5
KOL-Index: 11911 . IMPORTANCE: Interstitial lung abnormalities have been associated with lower 6-minute walk distance, diffusion capacity for carbon monoxide, and total lung capacity. However, to our knowledge, an association with mortality has not been previously investigated. OBJECTIVE: To investigate whether interstitial lung abnormalities are associated with increased mortality. DESIGN, SETTING, AND ...
Known for Interstitial Lung Abnormalities | Allcause Mortality | Pulmonary Disease | Higher Rate

Key People For Lung Function

Top KOLs in the world
#1
John L Hankinson
lung function coal miners airway obstruction
#2
Paul L Enright
cardiovascular health study lung function airway obstruction
#3
Ole Find Pedersen
gas films acoustic rhinometry nasal cavity
#4
Robert O Crapo
pulmonary function airway obstruction diffusing capacity
#5
Allan L Coates
cystic fibrosis lung function cardiac output
#6
Per Magnus Gustafsson
cystic fibrosis lung clearance ventilation inhomogeneity

Pulmonary and Critical Care Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. | Division of Pulmonary and Critical Care Medicine Brigham and Women's Hospital Boston MA. | Division of Pulmonary and Critical Care Medicine